Skip to main content

Vismodegib Dosage

Medically reviewed by Drugs.com. Last updated on May 3, 2023.

Applies to the following strengths: 150 mg

Usual Adult Dose for Basal Cell Carcinoma

150 mg orally once a day until disease progression or unacceptable toxicity

Comments:


Use: Treatment of adults with metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery and who are not candidates for radiation

Renal Dose Adjustments

No adjustment recommended.

Liver Dose Adjustments

No adjustment recommended.

Precautions

US BOXED WARNINGS:
EMBRYOFETAL TOXICITY:


CONTRAINDICATIONS:

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Storage requirements:

Monitoring:

Patient advice:

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.